Horizon 2020

January 1, 2012 in Archive

Horizon 2020 is the EU’s newly proposed research funding framework for 2014-2020.

European Union grants are an important element in delivering world-class research in London, both as a funding stream and in encouraging prestigious international collaborations.

  • 596 EU funded health projects at London Medicine higher education institutions (HEIs) between 2003 and 2011
  • £45,159,000 in EU funding for medical research at London Medicine HEIs (2009/10)
  • 50% of medical research papers by London Medicine HEIs have an international co-author (2005-2009)
  • EU funded grants enable London to create collaborations with renowned research bodies e.g. INSERM, Max Planck Society, Karolinska Institute

Horizon 2020

The Horizon 2020 proposals were launched in November 2011 and are currently being negotiated.

The three main priorities for Horizon 2020 are:

  • excellent science;
  • industrial leadership and;
  • societal challenges.

Horizon 2020 seeks to address six societal challenges, one of which is Health, demographic change and wellbeing. The proposed budget for the Health challenge is €9,077 million. Several priority areas for the Health challenge have been identified although specific research calls and budgets have not yet been agreed.

Find out more about the proposal on the Horizon 2020 website.

London Medicine activity

In January 2012 London Medicine hosted a seminar in Brussels to gain an understanding of Horizon 2020 and to identify suggestions for how the policy could enhance collaboration in health research across Europe.

Several policy points were identified and London Medicine will seek to influence Horizon 2020 by:

  • Writing to the UK government and MEPs in support of continued investment in research at the European level;
  • Seeking to influence the advisory group responsible for providing the detail in Horizon 2020 for the Health research priorities and the corresponding budgets and;
  • Providing the European Commission case studies about the successes and challenges in London HEI/SME research collaborations to inform their policy in this area.

This document is the summary note from the London Medicine seminar.